BCTX
Briacell Therapeutics Corp
NASDAQ: BCTX · HEALTHCARE · BIOTECHNOLOGY
$4.18
+3.98% today
Updated 2026-04-30
Market cap
$28.13M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-14.42
Dividend yield
—
52W range
$4 – $50
Volume
0.2M
Briacell Therapeutics Corp (BCTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1126.00 | $-87757.00 | $-89684.00 | $-151050.00 | $-318632.00 | $-656679.00 | $-382742.00 | $-381803.00 | $-397423.00 | $-1.19M | $-1.58M | $-1.91M | $-4.95M | $-5.12M | $-1.55M | $-9.89M | $-15.87M | $-31.89M | $-32.97M | $-39.07M |
| Capital expenditures | $0.00 | $0.00 | $89684.00 | $167106.00 | $496091.00 | $2.24M | $2.52M | $457679.00 | $157506.00 | $2260.00 | $3.00 | $4.00 | $3.00 | $5.00 | $0.00 | $4.00 | $0.00 | $3.00 | $624208.00 | $3.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | $76739.00 | $15919.00 | $443380.00 | $27725.00 | — | — | $396863.00 | $496209.00 | $218248.00 | $365492.00 | $46075.00 | $1686.00 | $1.97M | $3.07M | $2.19M | $1.80M | $776879.00 |
| Free cash flow | $1126.00 | $-87757.00 | $-179368.00 | $-318156.00 | $-814723.00 | $-2.89M | $-2.90M | $-839482.00 | $-554929.00 | $-1.19M | $-1.58M | $-1.91M | $-4.95M | $-5.12M | $-1.55M | $-9.89M | $-15.87M | $-31.89M | $-33.59M | $-39.07M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $-16.23M | — | — | — |